Lumeda Announces Appointment of Alexander Zinke as Chief Executive Officer

Experienced medical industry executive to lead the company in its next phase of commercialization and growth Rocky Hill, Connecticut – October 15, 2020 – Lumeda Inc., a biophotonics systems company advancing photodynamic therapy (PDT) for treating cancer, today announced the appointment of Alexander (Sandy) Zinke as Chief Executive Officer. Mr. Zinke will also join the company board of directors.    …

Lumeda Announces Formation of its Scientific Advisory Board

Prominent medical and scientific experts to help company advance development of PDT products Rocky Hill, Connecticut – June 22, 2020 – Lumeda Inc. (“Lumeda”), a biophotonics systems company advancing photodynamic therapy (PDT) for treating cancer, today announced the formation of its Scientific Advisory Board with the appointment of a panel of medical and scientific experts who will provide critical medical, …

Lumeda Enters License Agreement with Roswell Park Comprehensive Cancer Center

Company secures exclusive rights for intraoperative photodynamic therapy in the treatment of non-small cell lung cancer Rocky Hill, Connecticut – June 25, 2020 – Lumeda Inc. (“Lumeda”), a biophotonics systems company formed to advance photodynamic therapy for treating cancer, today announced the company has entered a license agreement with Roswell Park Comprehensive Cancer Center of Buffalo, New York (“Roswell Park”).  …